In a 47-year-old woman with a partial hysterectomy and one remaining ovary, do luteinizing hormone of 32.7 IU/L, follicle‑stimulating hormone of 21 IU/L, and estradiol of 146 pg/mL indicate perimenopause or early ovarian insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hormone Levels Indicate Perimenopause, Not Premature Ovarian Insufficiency

These hormone levels (LH 32.7 IU/L, FSH 21 IU/L, estradiol 146 pg/mL) in a 47-year-old woman with one remaining ovary indicate perimenopause rather than premature ovarian insufficiency (POI), as she is above the age threshold for POI diagnosis and her estradiol remains relatively preserved.

Key Diagnostic Distinctions

Why This is NOT POI

POI is specifically defined as ovarian insufficiency occurring before age 40 years 1. The diagnostic criteria require:

  • Amenorrhea or oligomenorrhea >4 months before age 40
  • FSH >25 IU/L on two separate occasions at least 4 weeks apart
  • Low estradiol levels 1

This patient fails to meet POI criteria on two critical points:

  1. Age: At 47 years, she is beyond the age cutoff for POI
  2. Estradiol level: Her estradiol of 146 pg/mL is not low—it's actually relatively preserved

Why This IS Perimenopause

The hormone pattern is consistent with perimenopause 2, 3:

  • Elevated FSH (21 IU/L): Perimenopausal women characteristically show FSH elevations (range 4-32 IU/g Cr) compared to younger reproductive-age women (3-7 IU/g Cr) 2
  • Elevated LH (32.7 IU/L): LH secretion increases in perimenopause (range 1.4-6.8 IU/g Cr vs. 1.1-4.2 in younger women) 2
  • Preserved estradiol (146 pg/mL): Critically, perimenopausal women often maintain or even show elevated estrone/estradiol levels compared to younger women, particularly in the follicular phase 2, 3. This is a hallmark feature distinguishing perimenopause from POI or established menopause

Impact of Prior Hysterectomy

The partial hysterectomy with one remaining ovary is relevant:

  • Hysterectomy, even with ovarian preservation, is associated with earlier decline in ovarian function 4, 5
  • Women with hysterectomy show higher FSH levels compared to controls (adjusted OR 1.5 for elevated FSH) 5
  • This may explain why she's showing perimenopausal changes at age 47 rather than closer to the typical age of 50-51

However, this surgical history does not change the fundamental diagnosis—she has perimenopause accelerated by prior surgery, not POI.

Clinical Implications

Hormonal Fluctuation Expected

Perimenopause is characterized by marked hormonal variability 3:

  • FSH levels fluctuate dramatically between cycles
  • Both ovulatory and anovulatory cycles occur unpredictably
  • No single hormone measurement reliably stages proximity to menopause 3

Management Differs from POI

Unlike POI patients who require hormone replacement therapy until at least age 51 to prevent cardiovascular disease and osteoporosis 1, perimenopausal women at age 47:

  • Are approaching natural menopause age
  • May not require the same intensive HRT approach
  • Should be counseled about symptom management rather than long-term replacement

Common Pitfall to Avoid

Do not diagnose POI based solely on elevated gonadotropins without considering age and estradiol levels. The FSH threshold of >25 IU/L for POI diagnosis 1 applies only to women under age 40. In women over 45, elevated FSH with preserved estradiol is the expected hormonal pattern of normal perimenopause 2, 3.

References

2
Research

Characterization of reproductive hormonal dynamics in the perimenopause.

The Journal of clinical endocrinology and metabolism, 1996

Related Questions

What is the interpretation of luteinizing hormone (LH) 18 IU/L and follicle‑stimulating hormone (FSH) 14 IU/L in a reproductive‑age female?
What do the terms follicular phase, ovulation, luteal phase, and postmenopausal refer to when interpreting hormone levels in a female?
Is an irregular menstrual cycle normal in a 43-year-old woman?
What is the appropriate treatment for an adult female with low luteinizing hormone (LH), follicle‑stimulating hormone (FSH), and estradiol levels?
What is the next step in managing a perimenopausal woman with irregular bleeding and menopausal range serum FSH (Follicle-Stimulating Hormone) levels?
Which specialty manages the treatment of pheochromocytoma?
What does prescribing doxycycline 100 mg by mouth twice daily (PO BID) for five days entail?
Will a Baker's cyst be visualized on ultrasound?
Why should Bupivacaine and lidocaine not be administered simultaneously during a peripheral nerve block for total knee arthroplasty?
Can continuous flow oxygen be used instead of pulse‑dose oxygen for a patient with COPD who cannot maintain target oxygen saturation during exertion?
What should be the rate setting for pulsed supplemental oxygen therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.